|*DISCLAIMER: This page is an unmoderated forum, and the opinions expressed herein do not necessarily reflect the viewpoint of The Johns Hopkins Medical Institutions. Patients are advised to consult their personal physicians before making any medical decisions. |
I am not sure about the low sensitivity. I read the article and attachments and, yes, it is not perfect (I am a retired scientist), but I am not seeing low sensitivity for all types of cancers. (Plus, of course, new research will undoubtedly improve results.)
I totaled up the rows and columns in Table 10, and yes, the results for an initial diagnosis of colorectum cancer vs the actual type is disappointing, but I am sure that work will have some focus on that.
But for other cancers, they were truly impressive to me. As one who has pancreatic cancer and now am involved with sharing the information with my extended family (including the next two generations),the potential seems like something that they should be aware of. I would like to be as specific as I can.
I am also not sure of your role, anonymous, in moving this test forward and your level of familiarity about what the people who developed this test are planning to do, which is what I really want to know. I was hoping that Dr. Hruban would respond, since he is one of the co-authors, and is listed as a co-author in 5 of the references.
Are you, anonymous, one of the co-authors or involved in moving this forward?
Also, my work as a scientist included costs/ benefits / risk and I do not expect that the world will ever discover or cure all cancers.
But, I would like to know from the authors what they planning to do next.
Reply to this message | Return to Main Message List